• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GELESIS, INC. PLENITY; INGESTED, TRANSIENT, SPACE OCCUPYING DEVICE FOR WEIGHT MANAGEMENT AND/OR WEIGHT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GELESIS, INC. PLENITY; INGESTED, TRANSIENT, SPACE OCCUPYING DEVICE FOR WEIGHT MANAGEMENT AND/OR WEIGHT Back to Search Results
Device Problems Difficult to Remove (1528); Physical Resistance/Sticking (4012)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 03/01/2022
Event Type  Injury  
Event Description
Plenity prescription weight loss supplement.It is supposed to expand in your stomach to make you feel full.The pill got stuck in my esophagus and expanded there.They did an endoscopy but the gel was so coagulated they had trouble removing it.They did eventually get it but there were complications and i was hospitalized overnight.This could have been life threatening, had i not gotten to the er right away or if it had lodged higher up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLENITY
Type of Device
INGESTED, TRANSIENT, SPACE OCCUPYING DEVICE FOR WEIGHT MANAGEMENT AND/OR WEIGHT
Manufacturer (Section D)
GELESIS, INC.
MDR Report Key13691859
MDR Text Key286851204
Report NumberMW5107918
Device Sequence Number1
Product Code QFQ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 03/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/07/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? Yes
Type of Device Usage A
Patient Sequence Number1
Treatment
BREO INHALER; BUPOPRION; DAILY VITAMIN ; DUPIXENT; VENLAFAXINE
Patient Outcome(s) Hospitalization; Life Threatening;
Patient Age47 YR
Patient SexFemale
Patient Weight101 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-